Related Experiment Video
Updated: Aug 19, 2026

Thermal Imaging to Study Stress Non-invasively in Unrestrained Birds
Published on: November 6, 2015
Effects of short-term glucocorticoids on cardiovascular biomarkers
Daniel J Brotman1, John P Girod, Mario J Garcia
1Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. dbrotma1@jhmi.edu
Context:
Glucocorticoids are known to acutely increase blood pressure, suppress inflammation, and precipitate insulin resistance. However, the short-term effects of glucocorticoids on other cardiovascular risk factors remain incompletely characterized.
Objective:
Our objective was to determine the effects of a short course of dexamethasone on multiple cardiovascular biomarkers and to determine whether suppression of morning cortisol in response to low-dose dexamethasone is correlated with cardiovascular risk markers in healthy volunteers.
Design:
We conducted a randomized, double-blind, placebo-controlled study.
Setting:
The study took place in a tertiary care hospital.
Study Subjects:
Twenty-five healthy male volunteers, ages 19-39 yr, participated in the study.
Intervention:
Subjects received either 3 mg dexamethasone twice daily or placebo for 5 d. Subjects also underwent a low-dose (0.5 mg) overnight dexamethasone suppression test.
Measures:
Parameters examined before and after the 5-d intervention included heart rate, blood pressure, weight, fasting lipid variables, homocysteine, renin, aldosterone, insulin resistance (homeostasis model assessment), high-sensitivity C-reactive protein, B-type natriuretic peptide, flow-mediated and nitroglycerin-mediated brachial artery dilatation, and heart rate recovery after exercise. All measurements were done in the morning hours in the fasting state.
Results:
Dexamethasone increased systolic blood pressure, weight, B-type natriuretic peptide, and high-density-lipoprotein-cholesterol. Dexamethasone decreased resting heart rate, high-sensitivity C-reactive protein, and aldosterone and tended to attenuate nitroglycerin-mediated vasodilatation. There was no effect on flow-mediated vasodilatation, diastolic blood pressure, triglycerides, low-density-lipoprotein-cholesterol, nonesterified fatty acids, homocysteine, or heart rate recovery. The response of circulating cortisol to low-dose dexamethasone had no significant correlation with any of the cardiovascular risk markers.
Conclusions:
Short-term glucocorticoids elicits both favorable and unfavorable effects on different cardiovascular risk factors. Manipulation of specific glucocorticoid-responsive physiological pathways deserves further study.
Insights
Short-term dexamethasone impacts cardiovascular risk factors, increasing blood pressure and HDL cholesterol while decreasing heart rate and CRP. These findings highlight mixed effects on cardiovascular health.
Area of Science:
- Endocrinology
- Cardiovascular Medicine
- Pharmacology
Background:
- Glucocorticoids acutely affect blood pressure, inflammation, and insulin resistance.
- Short-term impacts on other cardiovascular risk factors are not fully understood.
Purpose of the Study:
- To evaluate effects of a short dexamethasone course on cardiovascular biomarkers.
- To correlate morning cortisol suppression with cardiovascular risk markers in healthy volunteers.
Main Methods:
- Randomized, double-blind, placebo-controlled study in a tertiary care hospital.
- 25 healthy males received 3 mg dexamethasone twice daily or placebo for 5 days.
- Assessed cardiovascular risk markers, including lipids, blood pressure, and inflammatory markers.
Main Results:
- Dexamethasone increased systolic blood pressure, weight, BNP, and HDL-C.
- Decreased heart rate, hs-CRP, and aldosterone; attenuated nitroglycerin-mediated vasodilation.
- No significant correlation found between cortisol response and cardiovascular risk markers.
Conclusions:
- Short-term glucocorticoid use has mixed cardiovascular effects, both beneficial and detrimental.
- Further research into glucocorticoid-responsive pathways is warranted.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids